Aptevo shareholders reject charter amendment, approve stock issuance at special meeting

Aptevo Therapeutics Inc.

Proposal 1 (charter amendment) failed: FOR 929,933 / AGAINST 554,853 / ABSTAIN 24,490; required majority of outstanding shares.
Proposal 2 (stock issuance and warrant repricing) approved: FOR 306,069 / AGAINST 283,207 / ABSTAIN 10,620; 909,380 broker non-votes.
Proposal 3 (adjournment) approved: FOR 926,978 / AGAINST 561,064 / ABSTAIN 21,234.
Charter amendment defeat means Aptevo cannot implement the proposed changes without another vote.
Approved issuance relates to June 28 securities purchase agreement covering warrants with exercise price adjustments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.